Incidence and risk factors for intravenous immunoglobulin-related hemolysis: A systematic review of clinical trial and real-world populations.

Cuesta, Hillary; El Menyawi, Ibrahim; Hubsch, Alphonse; Hoefferer, Liane; Mielke, Orell; Gabriel, Susie; Shebl, Amgad

Cuesta, Hillary; El Menyawi, Ibrahim; Hubsch, Alphonse; Hoefferer, Liane; Mielke, Orell; Gabriel, Susie; Shebl, Amgad.

Afiliação

Cuesta H; CSL Behring, King of Prussia, Pennsylvania, USA.
El Menyawi I; CSL Behring AG, Bern, Switzerland.
Hubsch A; CSL Behring AG, Bern, Switzerland.
Hoefferer L; CSL Behring AG, Bern, Switzerland.
Mielke O; CSL Behring Innovation GmbH, Marburg, Germany.
Gabriel S; CSL Limited, Parkville, Melbourne, Australia.
Shebl A; CSL Behring Innovation GmbH, Marburg, Germany.

Transfusion ; 62(9): 1894-1907, 2022 09.

Article em En | MEDLINE | ID: mdl-35916266

Assuntos

Hemólise; Imunoglobulinas Intravenosas; Sistema ABO de Grupos Sanguíneos; Humanos; Imunoglobulinas Intravenosas/efeitos adversos; Incidência; Fatores de Risco

Palavras-chave

ABO blood group; hemolysis; intravenous immunoglobulin; isoagglutinins

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulinas Intravenosas / Hemólise Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google